BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11125884)

  • 1. Impact of TNFalpha, LTalpha, Fc gammaRII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patients.
    Knuchel MC; Speck RF; Schlaepfer E; Kuster H; Ott P; Günthard HF; Opravil M; Cone RW; Weber R
    AIDS; 2000 Dec; 14(17):2661-9. PubMed ID: 11125884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement dependent trapping of infectious HIV in human lymphoid tissues.
    Bánki Z; Kacani L; Rusert P; Pruenster M; Wilflingseder D; Falkensammer B; Stellbrink HJ; van Lunzen J; Trkola A; Dierich MP; Stoiber H
    AIDS; 2005 Mar; 19(5):481-6. PubMed ID: 15764853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy.
    Voltersvik P; Bostad L; Dyrhol-Riise AM; Eide GE; Røsok BI; Olofsson J; Asjö B
    J Acquir Immune Defic Syndr; 2006 Mar; 41(3):277-84. PubMed ID: 16540928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue.
    Talal AH; Monard S; Vesanen M; Zheng Z; Hurley A; Cao Y; Fang F; Smiley L; Johnson J; Kost R; Markowitz MH
    J Acquir Immune Defic Syndr; 2001 Jan; 26(1):1-7. PubMed ID: 11176263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV expression in surgical specimens.
    Orenstein JM
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):947-55. PubMed ID: 18671477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy.
    Andersson J; Fehniger TE; Patterson BK; Pottage J; Agnoli M; Jones P; Behbahani H; Landay A
    AIDS; 1998 Jul; 12(11):F123-9. PubMed ID: 9708402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
    Hogan LE; Vasquez J; Hobbs KS; Hanhauser E; Aguilar-Rodriguez B; Hussien R; Thanh C; Gibson EA; Carvidi AB; Smith LCB; Khan S; Trapecar M; Sanjabi S; Somsouk M; Stoddart CA; Kuritzkes DR; Deeks SG; Henrich TJ
    PLoS Pathog; 2018 Feb; 14(2):e1006856. PubMed ID: 29470552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.
    Montefiori DC
    Springer Semin Immunopathol; 1997; 18(3):371-90. PubMed ID: 9089955
    [No Abstract]   [Full Text] [Related]  

  • 9. Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.
    Notermans DW; Jurriaans S; de Wolf F; Foudraine NA; de Jong JJ; Cavert W; Schuwirth CM; Kauffmann RH; Meenhorst PL; McDade H; Goodwin C; Leonard JM; Goudsmit J; Danner SA
    AIDS; 1998 Jan; 12(2):167-73. PubMed ID: 9468365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza.
    Lund FE; Partida-Sánchez S; Lee BO; Kusser KL; Hartson L; Hogan RJ; Woodland DL; Randall TD
    J Immunol; 2002 Nov; 169(9):5236-43. PubMed ID: 12391242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection.
    Kuster H; Opravil M; Ott P; Schlaepfer E; Fischer M; Günthard HF; Lüthy R; Weber R; Cone RW
    Am J Pathol; 2000 Jun; 156(6):1973-86. PubMed ID: 10854220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features.
    Bartsch YC; Loos C; Rossignol E; Fajnzylber JM; Yuan D; Avihingsanon A; Ubolyam S; Jupimai T; Hirschel B; Ananworanich J; Lauffenburger DA; Li JZ; Alter G; Julg B
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue.
    Ruiz L; van Lunzen J; Arno A; Stellbrink HJ; Schneider C; Rull M; Castellà E; Ojanguren I; Richman DD; Clotet B; Tenner-Racz K; Racz P
    AIDS; 1999 Jan; 13(1):F1-8. PubMed ID: 10207538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph nodes during antiretroviral therapy.
    Stellbrink HJ; van Lunzen J
    Curr Opin Infect Dis; 2001 Feb; 14(1):17-22. PubMed ID: 11979110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques.
    Wallace M; Pyzalski R; Horejsh D; Brown C; Djavani M; Lu Y; Hanson JM; Mitchen JL; Perlman SB; Pauza CD
    Virology; 2000 Sep; 274(2):255-61. PubMed ID: 10964769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies.
    Cohen OJ; Pantaleo G; Lam GK; Fauci AS
    Springer Semin Immunopathol; 1997; 18(3):305-22. PubMed ID: 9089951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection.
    Putter H; Prins JM; Jurriaans S; Roos M; Ferguson NM; van Praag R; van der Hoek L; Schuitemaker H; Anderson RM; Goudsmit J; Lange JM; de Wolf F
    AIDS; 2000 Dec; 14(18):2831-9. PubMed ID: 11153664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy.
    Re MC; Schiavone P; Bon I; Vitone F; De Crignis E; Biagetti C; Gibellini D
    Int J Infect Dis; 2010 Nov; 14(11):e1008-12. PubMed ID: 20869896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection].
    Vergnon-Miszczycha D; Lucht F; Roblin X; Pozzetto B; Paul S; Bourlet T
    Med Sci (Paris); 2015 Dec; 31(12):1092-101. PubMed ID: 26672662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal cryptopatch formation in mice requires lymphotoxin alpha and the lymphotoxin beta receptor.
    Taylor RT; Lügering A; Newell KA; Williams IR
    J Immunol; 2004 Dec; 173(12):7183-9. PubMed ID: 15585839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.